These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8435209)

  • 1. Effect of whole body hyperthermia on cis-diamminedichloroplatinum (II)-induced antitumour activity and tissue Pt-distribution: do anaesthetics influence the therapeutic ratio?
    Wondergem J; Siddik ZH; Strebel FR; Bull JM
    Eur J Cancer; 1993; 29A(4):549-54. PubMed ID: 8435209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of anaesthetics on cisplatinum-induced toxicity at normal temperatures and during whole-body hyperthermia: the influence of NaCl concentration of the vehicle.
    Wondergem J; Strebel FR; Siddik ZH; Newman RA; Bull JM
    Int J Hyperthermia; 1988; 4(6):643-54. PubMed ID: 3171259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cis-diamminedichloroplatinum(II) combined with whole body hyperthermia on renal injury.
    Wondergem J; Bulger RE; Strebel FR; Newman RA; Travis EL; Stephens LC; Bull JM
    Cancer Res; 1988 Jan; 48(2):440-6. PubMed ID: 3335012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased therapeutic gain of combined cis-diamminedichloroplatinum (II) and whole body hyperthermia therapy by optimal heat/drug scheduling.
    Baba H; Siddik ZH; Strebel FR; Jenkins GN; Bull JM
    Cancer Res; 1989 Dec; 49(24 Pt 1):7041-4. PubMed ID: 2582445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of thermal enhancement of cis-diamminedichloroplatinum (II) induced renal and intestinal toxicities by whole body hyperthermia in the rat.
    Wondergem J; Bulger RE; Siddik ZH; Leygraaf JW; Strebel FR; Alonso M; Travis EL; Bull JM
    Int J Radiat Oncol Biol Phys; 1989 Jun; 16(6):1551-6. PubMed ID: 2722594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of carboplatin combined with whole body hyperthermia on normal tissue and tumor in rats.
    Ohno S; Siddik ZH; Baba H; Stephens LC; Strebel FR; Wondergem J; Khokhar AR; Bull JM
    Cancer Res; 1991 Jun; 51(11):2994-3000. PubMed ID: 2032236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic effect of whole-body hyperthermia combined simultaneously with cis-diamminedichloroplatinum (II) on normal tissue in rat.
    Wondergem J; Strebel FR; Stephens LC; Siddik ZH; Bull JM
    Int J Hyperthermia; 1995; 11(1):37-47. PubMed ID: 7714369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased therapeutic efficacy induced by tumor necrosis factor alpha combined with platinum complexes and whole-body hyperthermia in rats.
    Ohno S; Strebel FR; Stephens LC; Siddik ZH; Makino M; Klostergaard J; Tomasovic SP; Khokhar AR; Bull JM
    Cancer Res; 1992 Aug; 52(15):4096-101. PubMed ID: 1638521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective protection against cis-diamminedichloroplatinum(II)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate.
    Bodenner DL; Dedon PC; Keng PC; Katz JC; Borch RF
    Cancer Res; 1986 Jun; 46(6):2751-5. PubMed ID: 3009000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergism between alkylating agent and cis-platin with moderate local hyperthermia: the effect of multidrug chemotherapy in an animal system.
    Matsushita S; Reynolds R; Urano M
    Int J Hyperthermia; 1993; 9(2):285-96. PubMed ID: 8468510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haematological toxicity of carboplatin and cisplatin combined with whole body hyperthermia in rats.
    Ohno S; Strebel FR; Stephens LC; Siddik ZH; Baba H; Makino M; Khokhar AR; Bull JM
    Br J Cancer; 1993 Sep; 68(3):469-74. PubMed ID: 8353037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal failure and platinum pharmacokinetics in three patients treated with cis-diamminedichloroplatinum(II) and whole-body hyperthermia.
    Gerad H; Egorin MJ; Whitacre M; Van Echo DA; Aisner J
    Cancer Chemother Pharmacol; 1983; 11(3):162-6. PubMed ID: 6685578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomes as drug carrier system for cis-diamminedichloroplatinum (II). II. Antitumor activity in vivo, induction of drug resistance, nephrotoxicity and Pt distribution.
    Steerenberg PA; Storm G; de Groot G; Claessen A; Bergers JJ; Franken MA; van Hoesel QG; Wubs KL; de Jong WH
    Cancer Chemother Pharmacol; 1988; 21(4):299-307. PubMed ID: 3370737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upper hemibody infusion of cis-diamminedichloroplatinum (II) followed by systemic antidote, sodium thiosulfate, for lung metastasis in rats.
    Iwamoto Y; Aoki K; Kawano T; Baba T
    Clin Exp Metastasis; 1984; 2(3):261-70. PubMed ID: 6543704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Para-aminobenzoic acid suppression of cis-diamminedichloroplatinum(II) nephrotoxicity.
    Esposito M; Vannozzi MO; Viale M; Fulco RA; Collecchi P; Merlo F; De Cian F; Zicca A; Cadoni A; Poirier MC
    Carcinogenesis; 1993 Dec; 14(12):2595-9. PubMed ID: 8269632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of dithiocarbamates against toxicity of cis-diamminedichloroplatinum in mice.
    Shimada H; Takahashi K; Funakoshi T; Kojima S
    Biol Pharm Bull; 1993 Apr; 16(4):368-71. PubMed ID: 8358386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity, induction of cross-resistance, and nephrotoxicity of a new platinum analogue, cis-1,1-diaminomethylcyclohexaneplatinum(II) sulfate, and of cis-diamminedichloroplatinum(II) in an immunocytoma model in the LOU/M rat.
    de Jong WH; Steerenberg PA; Vos JG; Bulten EJ; Verbeek F; Kruizinga W; Ruitenberg EJ
    Cancer Res; 1983 Oct; 43(10):4927-34. PubMed ID: 6683993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal duration of whole body hyperthermia when combined with cis-diaminne-1,1-cychlobutane dicarboxylate platinum (II) (carboplatin).
    Kaneko T; Sakaguchi Y; Makino M; Matsuda H; Strebel FR; Jenkins GN; Bull JM
    Anticancer Res; 1997; 17(3C):1897-901. PubMed ID: 9216642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of adriamycin combined with whole body hyperthermia on tumor and normal tissues.
    Wondergem J; Stephens LC; Strebel FR; Baba H; Ohno S; Siddik ZH; Newman RA; Bull JM
    Cancer Res; 1991 Jul; 51(13):3559-67. PubMed ID: 2054792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of altered duration of 41.5 degrees C whole body hyperthermia in combination with cis-diamminedichloroplatinum (II) on tumor and normal tissue apoptosis and tumor response in rats.
    Toyota N; Strebel FR; Stephens LC; Rowe W; Matsuda H; Oshiro T; Jenkins GN; Bull JM
    Oncol Rep; 1998; 5(5):1231-6. PubMed ID: 9683841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.